Type(s) of Cancer
Lung
Lung
Study Phase
Phase 3
Study Completion Date
April 2012
April 2012
NCT00409188Uploaded 10-21-2015
Available for Download
PDS UID: LungNo_MerckKG_2007_145
A Multi-center Phase III Randomized, Double-blind Placebo-controlled Study of the Cancer Vaccine Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Non-small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease.
PDS UID: LungNo_Multipl_2018_231Go to Study
Enhancing the Analytic Capacity of LungNo_MerckKG_2007_145 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:




PROTOCOLEMR63325-001_start_v07_Redacted Clinical Study Protocol.pdf

CRFEMR63325-001_START_SAS annotated eCRF_.pdf.pdf

DATA DICTIONARYData Dictionary.pdf

DATA (COMPARATOR ARM)emr63325-001_START_Raw Data.zip